MX2012009172A - Composiciones liquidas que comprenden un agente de enfriamiento sin mentol y un espesante para tratar un sintoma respiratorio. - Google Patents

Composiciones liquidas que comprenden un agente de enfriamiento sin mentol y un espesante para tratar un sintoma respiratorio.

Info

Publication number
MX2012009172A
MX2012009172A MX2012009172A MX2012009172A MX2012009172A MX 2012009172 A MX2012009172 A MX 2012009172A MX 2012009172 A MX2012009172 A MX 2012009172A MX 2012009172 A MX2012009172 A MX 2012009172A MX 2012009172 A MX2012009172 A MX 2012009172A
Authority
MX
Mexico
Prior art keywords
liquid composition
thickener
treating
cooling agent
respiratory symptom
Prior art date
Application number
MX2012009172A
Other languages
English (en)
Inventor
Thomas Edward Huetter
Tracy L Grosick
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2012009172A publication Critical patent/MX2012009172A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción describe métodos para mejorar una sensación general de enfriamiento de una mucosa oral, el método comprende administrar una composición líquida que comprende un agente de espesamiento y/o un polímero mucoadhesivo, un refrescante sin mentol; y poner en contacto una mucosa oral con la composición líquida. La descripción también describe las composiciones líquidas.
MX2012009172A 2010-02-10 2011-02-09 Composiciones liquidas que comprenden un agente de enfriamiento sin mentol y un espesante para tratar un sintoma respiratorio. MX2012009172A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30298110P 2010-02-10 2010-02-10
PCT/US2011/024116 WO2011100267A1 (en) 2010-02-10 2011-02-09 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom

Publications (1)

Publication Number Publication Date
MX2012009172A true MX2012009172A (es) 2012-08-23

Family

ID=43981431

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012009172A MX2012009172A (es) 2010-02-10 2011-02-09 Composiciones liquidas que comprenden un agente de enfriamiento sin mentol y un espesante para tratar un sintoma respiratorio.

Country Status (9)

Country Link
US (1) US20110195042A1 (es)
EP (1) EP2533760A1 (es)
CN (1) CN102753145A (es)
AU (1) AU2011215947C1 (es)
BR (1) BR112012019921A2 (es)
CA (1) CA2788834A1 (es)
MX (1) MX2012009172A (es)
RU (1) RU2552334C2 (es)
WO (1) WO2011100267A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2849718B1 (de) 2012-05-16 2017-02-01 Symrise AG Mischungen mit verbesserter kühlwirkung
EP2730280B1 (en) * 2012-11-08 2018-05-09 Symrise AG A menthane carboxamide for the treatment of skin inflammation
PL2956120T3 (pl) * 2013-02-13 2020-08-10 The Procter & Gamble Company Leki o smaku anyżu
JP6794758B2 (ja) * 2015-10-21 2020-12-02 大正製薬株式会社 経口液体医薬組成物
US11534400B2 (en) 2016-06-03 2022-12-27 Societe Des Produits Nestle S.A. Compositions and methods for improving hydration of individuals having dysphagia
CN106267159A (zh) * 2016-09-09 2017-01-04 拉芳家化股份有限公司 一种口腔护理组合物
JP2019536769A (ja) * 2016-10-31 2019-12-19 スダ リミテッド 粘膜活性剤送達
CN110177542A (zh) * 2016-11-28 2019-08-27 强生消费者公司 包含黏膜粘着剂的液体组合物
WO2018221620A1 (ja) * 2017-05-31 2018-12-06 ライオン株式会社 歯磨剤組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738984A (en) * 1973-04-02 1988-04-19 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7560559B2 (en) * 2003-04-15 2009-07-14 Merck & Co., Inc. Polymorphic form of montelukast sodium
US20080300314A1 (en) * 2003-11-21 2008-12-04 Givaudan Sa Cooling Compounds
DE602004026619D1 (en) * 2003-11-21 2010-05-27 Givaudan Sa N-substituierte p-menthancarbonsäureamide
US7641926B2 (en) * 2004-08-25 2010-01-05 Cadbury Adams Usa, Llc Liquid-filled chewing gum composition
PT1791791T (pt) * 2004-09-27 2019-09-12 Special Water Patents B V Métodos e composições para tratamento de água
EP1948236B1 (en) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
CN101868253A (zh) * 2007-11-21 2010-10-20 宝洁公司 可用于咳嗽治疗的制剂、方法和试剂盒
JP2011520925A (ja) * 2008-05-22 2011-07-21 ジボダン エス エー 清涼組成物
WO2010019730A1 (en) * 2008-08-15 2010-02-18 The Procter & Gamble Company Synthesis of cyclohexane derivatives useful as sensates in consumer products
ES2626230T3 (es) 2008-11-20 2017-07-24 The Procter & Gamble Company Composiciones para la higiene personal que proporcionan una sensación refrescante mejorada
WO2010128026A2 (en) 2009-05-05 2010-11-11 Givaudan Sa Organic compounds

Also Published As

Publication number Publication date
BR112012019921A2 (pt) 2016-04-26
AU2011215947A1 (en) 2012-08-30
AU2011215947B2 (en) 2014-07-10
CA2788834A1 (en) 2011-08-18
CN102753145A (zh) 2012-10-24
AU2011215947C1 (en) 2014-07-24
RU2552334C2 (ru) 2015-06-10
RU2012133346A (ru) 2014-03-20
EP2533760A1 (en) 2012-12-19
US20110195042A1 (en) 2011-08-11
WO2011100267A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
MX2012009172A (es) Composiciones liquidas que comprenden un agente de enfriamiento sin mentol y un espesante para tratar un sintoma respiratorio.
EP2381957A4 (en) THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM LIMITING LUBRICATION
MY162146A (en) Pharmaceutical composition
IN2015DN01156A (es)
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
WO2013072932A3 (en) Oral care compositions
WO2011113013A3 (en) Methods and compositions for treating viral or virally-induced conditions
WO2014186742A3 (en) Anhydrous hydrogel composition
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
IN2012DN01869A (es)
MX2013006040A (es) Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
MX2011007930A (es) Conjugados de insulina cristalina.
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MY172292A (en) Vectors and sequences for the treatment of diseases
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
IN2012DN00624A (es)
MX2011003473A (es) Composiciones para el cuidado bucal.
PH12014501991A1 (en) Phenicol antibacterials
MX365427B (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas.
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
MX336369B (es) Uso de acido elagico como agentes anticaspa.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal